3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
13
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
8
Thrombocythemia, Essential
6
Polycythemia Vera
6
Myelodysplastic Syndromes
5
Leukemia
5
Recurrence
3
Neoplasms
3
Lymphoma, T-Cell
3
Graft vs Host Disease
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Thalassemia
1
Targeted Therapy
1
Prostatic Neoplasms
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Specimen Handling
2
Biopsy
2
Azacitidine
2
venetoclax
1
veliparib
1
pevonedistat
1
peginterferon alfa-2b
1
fludarabine phosphate
1
axatilimab
1
Whole-Body Irradiation
1
Topotecan
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hyperbaric Oxygenation
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Carboplatin
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
ruxolitinib
×
90 days
×
Clear all
No trials found.